Abstract
SARS-CoV-2 reinfections increased substantially after Omicron variants emerged. Large-scale community-based comparisons across multiple Omicron waves of reinfection characteristics, risk factors, and protection afforded by previous infection and vaccination, are limited. Here we studied ~45,000 reinfections from the UK's national COVID-19 Infection Survey and quantified the risk of reinfection in multiple waves, including those driven by BA.1, BA.2, BA.4/5, and BQ.1/CH.1.1/XBB.1.5 variants. Reinfections were associated with lower viral load and lower percentages of self-reporting symptoms compared with first infections. Across multiple Omicron waves, estimated protection against reinfection was significantly higher in those previously infected with more recent than earlier variants, even at the same time from previous infection. Estimated protection against Omicron reinfections decreased over time from the most recent infection if this was the previous or penultimate variant (generally within the preceding year). Those 14-180 days after receiving their most recent vaccination had a lower risk of reinfection than those >180 days from their most recent vaccination. Reinfection risk was independently higher in those aged 30-45 years, and with either low or high viral load in their most recent previous infection. Overall, the risk of Omicron reinfection is high, but with lower severity than first infections; both viral evolution and waning immunity are independently associated with reinfection.
Introduction
Early in the pandemic, SARS-CoV-2 reinfections were rare, with previous infections providing 80–90% protection. The emergence of the Omicron variant fundamentally changed this landscape due to its high number of mutations and ability to escape existing immunity. Most existing studies on reinfection rely on national testing programs, which often over-represent symptomatic individuals and those with easy access to healthcare. This paper addresses the need for a large-scale, community-based comparison across multiple Omicron waves to quantify risk factors, the duration of protection from vaccination, and the impact of "variant-specific" immunity using unbiased longitudinal data.
Methodology and Data
The researchers utilized data from the UK’s National COVID-19 Infection Survey (CIS), a longitudinal study that performed regular swab tests on participants regardless of symptoms. The study followed approximately 535,000 participants between April 2020 and March 2023, analyzing roughly 11.3 million swab tests and identifying ~45,000 confirmed reinfections.
To analyze this dataset, the team employed flexible parametric survival models to estimate reinfection risk across five distinct Omicron waves (BA.1 through XBB.1.5). They also used robust linear regression to compare Cycle threshold (Ct) values—a proxy for viral load—and multinomial logistic regression to analyze differences in self-reported symptoms.
Key Findings
The "Variant Proximity" Effect and Waning Immunity
Protection against reinfection is determined by both the timing and the nature of previous exposure. Protection against a new Omicron subvariant was significantly higher if the previous infection was a recent Omicron relative rather than an older variant (like Delta or Alpha), even when adjusted for the time elapsed. However, protection from the most recent infection or vaccination significantly decreased after 180 days, reinforcing the role of "hybrid immunity" (infection + vaccination) in maintaining a defense against evolving subvariants.
Viral Load and Symptom Severity
Reinfections consistently showed higher Ct values (indicating lower viral loads) and a 40–50% lower likelihood of "classic" symptoms (fever, cough, loss of taste/smell) compared to first infections. The median Ct value was 23 for first infections, 25 for second, and 26 for third, indicating a statistically significant trend toward lower viral loads in subsequent infections.
Risk Factors
Reinfection risk was independently higher in adults aged 30–45. Interestingly, risk was also higher for those who had either a very low or very high viral load in their previous infection, suggesting that a weak initial immune response or a massive initial viral challenge might both predispose an individual to future reinfection.
Discussion
While reinfection is common in the Omicron era, it is generally characterized by lower severity than first infections. The study highlights that reinfection risk is driven by a combination of waning immunity and rapid viral evolution.
Limitations of the study include the potential for missed asymptomatic infections between monthly survey windows and the lack of direct data on clinical outcomes like hospitalizations or deaths. Future work is needed to monitor how hybrid immunity holds up against increasingly distant recombinant variants and to assess the long-term impact of repeated infections on population health.
Summary updated